Thirty three children with classical galactosaemia diagnosed through newborn screening are considered. It is concluded that cataract formation has a direct relationship with poor dietary control. Erythrocyte galactose-lphosphate (Gal-1-P) levels do not correspond to cataract formation unless many times higher than normal. The value of crystalline lens biomicroscopy is confirmed as a useful method for monitoring the dietary and biochemical control in classical galactosaemia. (BrJ Ophthalmol 1993; 77: 162-164) Galactosaemia results from an error of galactose metabolism caused by a deficiency of any one of the three enzymes; galactokinase, transferase, and epimerase.' Galactosaemia is a rare cause of congenital cataract, but should always be considered in the differential diagnosis because of the reversibility of the condition after an early initiation of the treatment. All types of galactosaemia cause cataract due to the activation of the aldose reductase shunt and accumulation ofgalactitol in the crystalline lens. In classical galactosaemia galactitol also accumulates in other tissues such as the liver and the brain.
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Classical galactosaemia, which has an incidence in Ireland of one in 23 000 births,2 is due to a defective gene mapped on human chromosome 9, which is coded for the enzyme galactose-lphosphate uridyl transferase (GPUT). It is inherited as an autosomal recessive condition.3 GPUT deficiency causes a multi-organ illness with cataract formation, hepatomegaly, and mental retardation. 4 We previously reported 17 children with classical galactosaemial and demonstrated the importance of early diagnosis and tight biochemical control in prevention of cataract, and highlighted the importance of slit-lamp biomicroscopy.
In this study we discuss the ophthalmic findings in 33 homozygous children with transferasedeficient galactosaemia diagnosed by newborn screening and on treatment. We include the 16 out of 17 children with galactosaemia previously reported.
Patients and methods There were 15 females and 18 males, with a mean observation time of years (16 of them observed for 10 years). Galactosaemia was diagnosed in 13 at birth, 11 by the fourth day, four by the 11th day, two by the 20th day, one in the sixth week, one in the third month, and one in the eighth year of life. They were diagnosed as a result of a national neonatal screening programme for galactosaemia, coupled with screening for phenylketonuria, homocystinuria, and maple-syrup urine disease. The blood spot test for galactosaemia using the Guthrie card is based on the E coli metabolite inhibition assay, in which the inhibition of the growth of a transferase deficient E coli mutant by galactose is used. 6 The Beutler erythrocyte transferase assay,7 plasma galactose, and erythrocyte galactose-l-phosphate (Gal-l-P) levels were checked in the cases which were positive on screening. High risk newborns who had older siblings with galactosaemia were put on a galactose-free diet at birth and the Beutler test and erythrocyte Gal-l-P levels were measured.
Patients were monitored by the inherited metabolic and paediatric ophthalmology units after the diagnosis and introduction of a galactose-free diet. The plasma galactose and erythrocyte Gal-1-P levels were frequently assessed. The ophthalmic assessment included visual acuity, motility, retinoscopy, slit-lamp biomicroscopy, and funduscopy. The ophthalmic findings, especially the crystalline lens opacities, were compared with the mean biochemical control, as reflected by the mean erythrocyte Gal-l-P level.
Comparison was also made with the dietary compliance which was assessed by the metabolic unit dietician. Five other children failed to attend for their appointments and were not included in this study.
Results
The 33 children were divided into three groups: very good, good, and fair biochemical control, on the basis of their mean erythrocyte Gal-l-P levels ( Table 1) . Four had no medical problems at the time of the diagnosis. Twenty two had jaundice, six had septicaemia, four had hepatomegaly with gastrointestinal disturbances. In their last review five had speech delay, four had low IQ and developmental delay ( Table 2) . Fifteen children had a positive family history of galactosaemia, with one or more siblings involved. Twelve children developed lens opacities in the form of posterior subcapsular, cortical, and nuclear minute opacities. One child (case 13) had familial autosomal dominant nuclear cataract which was stationary.
In the group with very good biochemical control, 13 patients had no cataract and 1 had congenital cataract (case 13). Two patients (cases 17 and 27) developed lens opacities later which were still present at the end of the study. Six other cases in this group (1, 5, 9, 10, 20, 25) with lens opacities at the beginning of the study cleared later. The remaining patient (case 11), a 9-year-old girl, on the diet since day 1, initially developed peripheral axial lens opacities at age 2-5 years during a 3 month period off the diet. On re-introduction of the diet, the opacities regressed completely over 6 months. Lens opacities developed 2 years later after another period of poor compliance. These regressed over a period of 3 years with tighter biochemical control.
In the good biochemical control group two had cataracts. One patient (case 4) had lens opacities at the start but they cleared later. The other (case 15), a 10-year-old boy, on the diet since day 1 17 with more than 7 years) reinforces our previous study of the usefulness of slit-lamp biomicroscopy. We also believe that the mean level of erythrocyte Gal-1-P does not correspond with the formation of lens opacities. Newer biochemical measurements are yet to be introduced.
